Abstract
Objective: to report cases of Telogen effluvium (T.E) as a sequele of COVID 19
 Material and methods: Ten patients were reported between May and august 2021with median age group of 21years. There were five males and five females in the study. All the cases were diagnosed with positive RTPCR when they had COVID and recovered fully without need for hospitalization. T.E occurred in our group after median of two months (range 1-2months) following COVID 19 infection. Detailed medical history of all the patients was taken.
 Results: all the ten cases showed early onset of T.E within three months of infection.
 Keywords: Telogen Effluvium, Covid 19, RTPCR
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
